What medication should be prescribed for a patient experiencing a transient ischemic attack (TIA) with right-sided weaknesses?

The appropriate medication to prescribe for a patient experiencing a transient ischemic attack (TIA) with right-sided weaknesses is aspirin (ASA) or clopidogrel (Plavix). This choice is based on clinical guidelines that recommend the use of antiplatelet therapy as the first-line treatment for TIA. Antiplatelet agents help reduce the risk of subsequent strokes by preventing platelet aggregation, thereby improving blood flow in the event of an occlusion.

In the context of a TIA, initiating antiplatelet therapy can significantly lower the risk of a major stroke, particularly within the first 90 days following the event. Aspirin is typically the first choice, but if a patient has had a prior stroke or is intolerant to aspirin, clopidogrel may be prescribed as an alternative.

This choice is further supported by current clinical practice guidelines which emphasize the importance of managing risk factors and providing preventive measures after a TIA.

While warfarin is an anticoagulant that is useful in specific situations such as atrial fibrillation or certain types of embolic strokes, it is generally not indicated for TIA management unless there are other underlying conditions warranting its use. Statins, on the other hand, can help in the